Every year, medical science and technology seem to advance at an ever more rapid pace, bringing hope for breakthroughs on serious illnesses and debilitating conditions. Intermountain has a long history of healthcare innovation, and we continue to build on that legacy.
Years ago, we organized clinicians and medical experts into 10 Clinical Program teams covering most of the clinical conditions we treat. These teams continue to serve us today as they work together reviewing medical literature, evaluating processes and data, and developing evidence-based best practices that caregivers can apply to treat patients in a consistent and effective way.
This section highlights examples of medical science advancements and clinical program implementation in 2018.
Neonatologist Erick Ridout, MD, at Intermountain Dixie Regional Medical Center, has helped care for hundreds of preemies needing critical care. His work to reduce needle draws in preemies has significantly improved care and outcomes while also reducing costs. In this animated illustration of his StoryCorps conversation, Dr. Ridout remembers Macy, one of the first babies for which he counted pokes.
Faced with complex surgery to remove a large, precariously placed tumor behind Cheryl Leward’s left eye, doctors at Intermountain Medical Center collaborated and worked quickly with Intermountain Healthcare’s Transformation Lab to create and study a 3D-printed model of the tumor in intricate detail. Having the model before surgery helped doctors anticipate what they would find and better explain how the surgery would be done, which Cheryl says provided a surprising emotional lift.
A caregiver team at Intermountain Utah Valley Hospital activated the Neurosciences Clinical Program’s stroke procedures for a patient thought to have experienced a seizure but who, in fact, was suffering a stroke. The team’s timely activation of the well-understood and practiced steps made a major difference in the patient’s life.
When a patient in southwestern Utah was diagnosed with stage IV kidney cancer, he was told he had only months to live. After having the kidney removed, he connected with Intermountain Precision Genomics for a personalized treatment process that landed on a targeted immunotherapy matching his DNA. His body responded quickly as tumors began shrinking and masses began disappearing.